홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Diisopropylethylamine → HCID 22710467, 화합물

HRID 352976
노트
인쇄 미리보기

반응식

HRID 352976 반응식
Cl.[Cl:2][C:3]1[CH:4]=[C:5]2[C:9](=[CH:10][CH:11]=1)[NH:8][C:7]([S:12]([N:15]1[CH2:20][CH2:19][N:18]([C:21]([C:23]3[S:24][C:25]4[CH2:26][NH:27][CH2:28][CH2:29][C:30]=4[N:31]=3)=[O:22])[CH:17]([CH2:32][C:33]([N:35]3[CH2:40][CH2:39][O:38][CH2:37][CH2:36]3)=[O:34])[CH2:16]1)(=[O:14])=[O:13])=[CH:6]2.C(N(C(C)C)CC)(C)C.[C:50](=O)([O:58]C1C=CC([N+]([O-])=O)=CC=1)[O:51][CH:52]([O:54][C:55](=[O:57])[CH3:56])[CH3:53]>C(O)C>[C:55]([O:54][CH:52]([O:51][C:50]([CH:28]1[NH:27][CH2:26][C:25]2[S:24][C:23]([C:21]([N:18]3[CH2:19][CH2:20][N:15]([S:12]([C:7]4[NH:8][C:9]5[C:5]([CH:6]=4)=[CH:4][C:3]([Cl:2])=[CH:11][CH:10]=5)(=[O:13])=[O:14])[CH2:16][CH:17]3[CH2:32][C:33]([N:35]3[CH2:36][CH2:37][O:38][CH2:39][CH2:40]3)=[O:34])=[O:22])=[N:31][C:30]=2[CH2:29]1)=[O:58])[CH3:53])(=[O:57])[CH3:56]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 3

HCID 81531DiisopropylethylamineHCID 117805601-acetoxyethyl p-nitrophenyl carbonateHCID 22709979HCID 22709979, 화합물

생성물 1

HCID 22710467HCID 22710467, 화합물

시약·촉매·용매 1

HCID 702Ethanol용매

실험 절차

In ethanol (6 ml) was dissolved 4-[(5-chloroindol-2-yl)sulfonyl]-2-[[(morpholin-4-yl)carbonyl]methyl]-1-[(4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]piperazine hydrochloride (200 mg), followed by the addition of diisopropylethylamine (83 μl) and 1-acetoxyethyl p-nitrophenyl carbonate (128 mg). The resulting mixture was stirred at room temperature for 5 hours. The solvent was distilled off under reduced pressure. Methylene chloride and an aqueous solution of sodium bicarbonate were added and the mixture was separated into layers. The organic layer was dried over anhydrous sodium sulfate and the filtrate was concentrated. The residue was purified by chromatography on a silica gel column (1-2% methanol-methylene chloride). The product was dissolved in ethyl acetate, followed by crystallization from diethyl ether, whereby the title compound (100 mg) was obtained as colorless powder.

후처리

  1. distillationThe solvent was distilled off under reduced pressure
  2. additionMethylene chloride and an aqueous solution of sodium bicarbonate were added
  3. customthe mixture was separated into layers
  4. dry with materialThe organic layer was dried over anhydrous sodium sulfate
  5. concentrationthe filtrate was concentrated
  6. customThe residue was purified by chromatography on a silica gel column (1-2% methanol-methylene chloride)
  7. dissolutionThe product was dissolved in ethyl acetate
  8. customfollowed by crystallization from diethyl ether, whereby the title compound (100 mg)
  9. customwas obtained as colorless powder

출처 및 근거

ORD 기록
ord-472e53be61b049b898b10733d06c906d
출처 데이터셋
uspto-grants-2004_06
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06747023B1

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트